Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

[How to prolong life of patients at high cardiovascular risk. Features of rosuvastatin].

Drapkina OM, Korneeva ON.

Kardiologiia. 2012;52(8):89-92. Review. Russian. No abstract available.

PMID:
23098406
2.

[Lipid lowering by rosuvastatin: how do statins differ?].

Laufs U.

Dtsch Med Wochenschr. 2015 Mar;140(5):313. doi: 10.1055/s-0041-100713. Epub 2015 Mar 3. Review. German. No abstract available.

PMID:
25734669
3.

Is Jupiter also a god of primary prevention?

Accad M, Fred HL.

Tex Heart Inst J. 2010;37(1):6-7. No abstract available.

4.

[Rosuvastatin has no effect on clinical outcomes in patients with heart failure. Results of the GISSI-HF trial].

Preorazhenskiĭ DV.

Kardiologiia. 2009;49(4):64-5. Russian. No abstract available.

PMID:
19463122
5.

Rosuvastatin in patients undergoing hemodialysis.

Kassimatis TI, Konstantinopoulos PA.

N Engl J Med. 2009 Jul 2;361(1):93; author reply 94-5. No abstract available.

PMID:
19579277
6.

Rosuvastatin in patients undergoing hemodialysis.

de Oliveira JM.

N Engl J Med. 2009 Jul 2;361(1):93-4; author reply 94-5. No abstract available.

PMID:
19579278
7.

Rosuvastatin outcomes study JUPITER closes early due to evidence of benefit.

[No authors listed]

Cardiovasc J Afr. 2008 Mar-Apr;19(2):117. No abstract available.

8.

[Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)].

Mareev VIu.

Kardiologiia. 2008;48(1):74-5. Russian. No abstract available.

PMID:
18261000
9.

Rosuvastatin in patients with elevated C-reactive protein.

Jenny-Avital ER.

N Engl J Med. 2009 Mar 5;360(10):1039; author reply 1041-2. No abstract available.

PMID:
19271275
10.

FDA approves a statin therapy for some: certain, asymptomatic individuals targeted.

Mitka M.

JAMA. 2010 Apr 7;303(13):1242-3. doi: 10.1001/jama.2010.342. No abstract available.

PMID:
20371776
11.

Rosuvastatin in patients with elevated C-reactive protein.

Koller MT, Bucher HC, Steyerberg EW.

N Engl J Med. 2009 Mar 5;360(10):1041; author reply 1041-2. No abstract available.

PMID:
19271276
12.

Rosuvastatin and primary cardiovascular prevention. Continue to use pravastatin or simvastatin.

[No authors listed]

Prescrire Int. 2011 Apr;20(115):94. No abstract available.

PMID:
21648210
13.

Rosuvastatin in patients with elevated C-reactive protein.

Chan PS, Nallamothu BK, Hayward RA.

N Engl J Med. 2009 Mar 5;360(10):1039; author reply 1041-2. No abstract available.

PMID:
19271273
14.

JUPITER strikes earth.

Fuster V, Bansilal S.

Nat Clin Pract Cardiovasc Med. 2009 Mar;6(3):159. doi: 10.1038/ncpcardio1454. No abstract available. Erratum in: Nat Clin Pract Cardiovasc Med. 2009 May;6(5):326.

PMID:
19234496
15.

[Hypercholesterolemia, practical guidelines].

Dallongeville J, Ferrières J, Schuster H, Farnier M, Lepen C.

Presse Med. 2004 Sep 25;33(16):1129-31. Review. French. No abstract available.

PMID:
15523276
16.

Will statins be an effective anti-inflammatory intervention for prevention of cardiovascular disease in patients with HIV?

Dubé MP.

J Infect Dis. 2014 Apr 15;209(8):1149-50. doi: 10.1093/infdis/jiu015. Epub 2014 Jan 9. No abstract available.

PMID:
24415787
17.

[Statin cuts cardiovascular risk in half].

Einecke D.

MMW Fortschr Med. 2008 Dec 4;150(49-50):12-3. German. No abstract available.

PMID:
19133364
18.

Rosuvastatin and cardiovascular continuum when time is important.

Barrios V, Escobar C.

J Am Coll Cardiol. 2010 Apr 13;55(15):1645-6; author reply 1646. doi: 10.1016/j.jacc.2009.12.031. No abstract available.

19.

Targeting HDL-cholesterol to reduce residual cardiovascular risk.

Iacob AO, Choudhury RP.

Curr Opin Lipidol. 2012 Apr;23(2):172-4. doi: 10.1097/MOL.0b013e32835135bd. Review. No abstract available.

PMID:
22418577

Supplemental Content

Support Center